tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Takeda announces FDA approval of Gammagard Liquid ERC

Takeda (TAK) announced that the FDA has approved Gammagard Liquid ERC with less than or equal to two microgram/mL IgA in a 10% solution, the only ready-to-use liquid immunoglobulin therapy with low immunoglobulin A content, as replacement therapy for people two years of age and older with primary immunodeficiency.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1